REG - IQE PLC - IQE plc: Result of AGM

IqeAnnouncement

Mon 13:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250630:nRSd0103Pa&default-theme=true

RNS Number : 0103P  IQE PLC  30 June 2025

IQE plc

 

Cardiff, UK

30 June 2025

 

 

Results of Annual General Meeting

 

 

IQE plc (AIM:  IQE, "IQE" or the "Group"), the leading global supplier of
compound semiconductor wafer products and advanced material solutions, is
pleased to announce that at its 2025 Annual General Meeting, held today in
London, UK, all resolutions were duly passed.

Resolution 1: Receipt of Directors' Report & Financial Statements

For: 424,229,796 (99.96%)

Against: 168,539 (0.04%)

Withheld: 271,856

 

Resolution 2: Approval of the Directors' Annual Report on Remuneration

For: 422,991,031 (99.68%)

Against: 1,345,167 (0.32%)

Withheld: 333,993

 

Resolution 3: To elect Mark Cubitt

For: 422,817,004 (99.63%)

Against: 1,558,455 (0.37%)

Withheld: 294,732

 

Resolution 4: To re-elect Jutta Meier

For: 423,745,702 (99.85%)

Against: 641,359 (0.15%)

Withheld: 283,130

 

Resolution 5: To re-elect Carol Chesney

For: 423,523,018 (99.80%)

Against: 829,978 (0.20%)

Withheld: 317,195

 

Resolution 6: To re-elect Victoria Hull

For: 423,056,044 (99.69%)

Against: 1,313,760 (0.31%)

Withheld: 300,387

 

Resolution 7: To re-elect Maria Marced

For: 423,438,866 (99.78%)

Against: 930,938 (0.22%)

Withheld: 300,387

 

Resolution 8: To re-elect Bamdad Bastani

For: 423,051,528 (99.69%)

Against: 1,320,376 (0.31%)

Withheld: 298,287

 

Resolution 9:  To re-elect Harmesh Suniara

For: 423,072,193 (99.69%)

Against: 1,299,711 (0.31%)

Withheld: 298,287

 

Resolution 10:  Reappointment of auditor

For: 423,401,900 (99.82%)

Against: 784,071 (0.18%)

Withheld: 484,220

 

Resolution 11:  Directors' authority to allot shares

For: 422,247,638 (99.50%)

Against: 2,131,629 (0.50%)

Withheld: 290,924

 

Resolution 12:  Disapplication of pre-emption rights

For: 413,276,828 (97.40%)

Against: 11,029,050 (2.60%)

Withheld: 364,313

 

Resolution 13:  Disapplication of pre-emption rights (additional authority)

For: 412,669,486 (97.26%)

Against: 11,636,381 (2.74%)

Withheld: 364,324

 

Contacts:

 

IQE plc

+44 (0) 29 2083 9400

Mark Cubitt

Jutta Meier

Amy Barlow

 

Peel Hunt (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Ben Cryer

Kate Bannatyne

Adam Telling

 

Deutsche Numis (Joint Broker)

+44 (0) 20 7260 1000

Simon Willis

Hugo Rubinstein

Iqra Amin

 

Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Chloe Francklin: +44 (0)78 3497 4624

ABOUT IQE

http://iqep.com
(https://www.globenewswire.com/Tracker?data=yZf7NKp1JKLALUCxlBuC8wkLnLAqoe5-kjjIlkMIDci9q9W0x_02bwZV-eorSbpLXZxy4zi3xHh-O4FM8nWjeg==)

 

 

IQE is the leading global supplier of advanced compound semiconductor wafers
and materials solutions that enable a diverse range of applications across:

 

·    Smart Connected Devices

·    Communications Infrastructure

·    Automotive and Industrial

·    Aerospace and Security

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in
this market which has high barriers to entry. IQE supplies the global market
and is enabling customers to innovate at chip and OEM level. By leveraging the
Group's intellectual property portfolio including know-how and patents, it
produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with employees across manufacturing
locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in
London.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGEAFKEDAPSEFA